New regimen for treatment of irritable bowel syndrome with emphasis on Sulpride as the sole maintenance therapy

@article{ElReshaid2019NewRF,
  title={New regimen for treatment of irritable bowel syndrome with emphasis on Sulpride as the sole maintenance therapy},
  author={Kamel El-Reshaid and Shaikha Al-Bader},
  journal={Journal of Drug Delivery and Therapeutics},
  year={2019}
}
The efficiency and safety of Sulpirid (50 mg twice/daily) was assessed in 563 adult patients with 6 groups of patients with irritable bowel syndrome (IBS) who had failed dietary therapy.  The groups included; patients without previous treatment (n: 137), patients who had received a muscarinic antagonists (n: 65), an anticholinergic/benzodiazepine combination (n: 187), a tricyclic antidepressants (n: 62), a selective serotonin reuptake inhibitors (SSRIs) (n: 48) and an antiflatulent (n: 64… 
1 Citations

Tables from this paper

References

SHOWING 1-10 OF 19 REFERENCES

Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

Antidepressants and some psychological therapies are effective treatments for IBS, and summary estimates of treatment effect have remained remarkably stable since the previous meta-analysis.

Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches.

Current issues related to IBS, including symptom presentation, diagnosis, and current treatment options are addressed and benefits and side effects of currently available pharmacological regimens and other symptom management strategies are summarized.

Peripherally acting therapies for the treatment of irritable bowel syndrome.

  • R. Saad
  • Medicine
    Gastroenterology clinics of North America
  • 2011

The burden of illness of irritable bowel syndrome: current challenges and hope for the future.

  • D. Hulisz
  • Medicine
    Journal of managed care pharmacy : JMCP
  • 2004
Though cost-effectiveness data on specific pharmacologic classes targeted at the multiple symptoms of IBS are not yet available, ongoing efforts may help promote timely IBS diagnosis and patient satisfaction with care, optimally decreasing the use of health care resources.

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Multivariate statistical analyses suggest that gastrointestinal disorders, psychiatric disorders, and nongastrointestinal somatic disorders are distinct disorders and not manifestations of a common somatization disorder, but their strong comorbidity suggests a common feature important to their expression, which is most likely psychological.

Costs of irritable bowel syndrome in the UK and US

An overview of studies addressing the direct and indirect costs of IBS in the US and the UK is provided to define strategies to help IBS patients improve their quality of life and reduce related costs.

Irritable Bowel Syndrome: A Review Article

A review of recent studies on the prevalence of IBS in Iran and appropriate methods for management of patients affected by IBS is set out.

The Association of Irritable Bowel Syndrome and Somatization Disorder

In this university-based office setting, the association of psychiatric features with IBS appears heterogeneous predicated on whether SD is present, and clinicians should consider whether patients with functional disorders have SD, a diagnosis that indicates specific clinical management strategies.

Food: the forgotten factor in the irritable bowel syndrome.